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It is generally accepted that the graft-versus-host (GVH)  1 reaction represents 
an immunological phenomenon called  forth by  the  introduction  of  immuno- 
competent  cells  into  a  host  carrying different  transplantation  antigens  and 
incapable of rejecting the grafted cells  (1, 2). Despite numerous studies,  the 
actual mechanisms of the GYH reaction are poorly understood and, although 
there is ample evidence that some of the grafted cells proliferate and differen- 
tiate in the recipient lymphoid organs (3), no attempt has been made to assess 
their relative significance. 
Previous in vitro studies have shown that transplantation immunity in mice 
is  characterized by  the  development of  at  least  two  types  of  effector cells, 
namely cells which produce and release alloantibody, and cells which  display 
a cytotoxic activity against target cells carrying the sensitizing alloantigens (4). 
The present study was undertaken to determine whether similar effector cells 
also appeared during  the  GVH reaction. Advantage was  taken of the  avail- 
ability  of two  in  vitro assay  systems allowing  the  independent detection of 
lyric alloantibody plaque-forming cells  (PFC)  and  of cytotoxic lymphocytes 
(CL) using the same target cells (5-7). It was found that both types of effector 
cells were present in spleens of heavily-irradiated mice injected 4-5 days earlier 
with allogeneic spleen cells.  Specificity studies indicated that the effector cells 
were of the donor genotype and were specifically sensitized against  the host 
alloantigens. Clear evidence for a  different origin of alloantibody PFC and CL 
was obtained by studying their susceptibility to treatment with anti~-serum. 
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Materials and Methods 
MCee.--C57BL/6J, DBA/2J,  A/J,  C3H/J,  BALB/cJ,  and  AKR/J  mice were  obtained 
from the colonies maintained in our institute or from the Jackson Laboratory, Bar Harbor, 
Maine. Mice of either sex were used at 2-4 months of age. 
Target Cells.--Tumor cells syngeneic to various strains of mice were maintained in vitro 
by serial passages as described previously  (5).  ~hey were used as target cells carrying allo- 
antigens of the DBA/2~ (P-815-X2 mastocytoma cells), C57BL/6 (EL4 lymphoma cells), or 
A  strains (¥AC  leukemia cells).  Peritoneal macrophages were used as the source of target 
cells carrying C~H alloantigens. 
Cell Tramfer.--Spleen cells from normal mice were obtained as described previously  (5). 
Recipient mice received 800 R  whole body X-irradiation 2  hr before intravenous injection 
of 50-100 X  106 spleen cells. They were exsangninated on days 4-5  after  transfer and  the 
spleens of each experimental group  (5-8 mice/group) were pooled before preparation of cell 
suspensions as indicated above (5). 
Assay for AUoantibody Plaque-Forming  Cd/s.---Details of the method have been published 
elsewhere  (7). In brief, spleen cell fractions  (3-6  X  106 cells)  were mixed in agarose with 
2  X  106 target cells and the cell mixture was then evenly spread on microscope slides. After 
incubation for 1 hr at 37°C, the slides were washed and incubated for 1 hr with rabbit serum 
as a  source of complement. After washing, the slides were incubated overnight with Eagle's 
medium containing 10% calf serum. The following day,  the slides were washed, fixed  with 
95% ethanol, and stained with Giemsa. 
Assay for Cytotoxic Lymphocytes.--The in vitro cytotoxic activity of sensitized lymphocytes 
was determined according to the method described previously (6, 8). Cell mixtures containing 
a  standard concentration of 51Cr-labeled  target cells (1  X  105 cells/ml) and varying concen- 
trations of spleen cells (ranging from 10 X  105 to I0 X  l0  T cells/ml) were prepared in Eagle's 
medium with 10•  inactivated calf serum. Volumes of 0.25 ml of the reaction mixtures were 
placed in flat-bottomed tubes and incubated at 37°C. Mter various incubation periods, 1.75 
ml volumes of phosphate-buffered saline were added to each tube. After centrifugation at 700 
g for 5 rain, 1 ml volumes of the supernatant fluid were carefully removed and placed in glass 
tubes for assessment of radioactivity in a well-type gamma counter. Total 51Cr incorporation 
was determined by measurement of radioactivity of 0.25 ml samples of the reaction mixtures. 
Maximal 51Cr release was determined by incubating 0.25 ml samples of the reaction mixtures 
with 1.75 ml of distilled water at 37°C for 6 hr. Mter centrifugation at 700 g for 5 rain, 1 ml 
volumes of the supernatant fluid were counted  for  radioactivity.  Spontaneous  51Cr release 
was determined after incubation of 51Cr-labeled  target cells with normal spleen cells instead 
of sensitized spleen cells.  This release was identical to ~lCr release from labeled target cells 
incubated without spleen cells.  Results are expressed as per cent of specific cytotoxicity using 
the following formula: 
experimental ~lCr release -- spontaneous 5xCr release 
X  100 
maximal 6~Cr release -- spontaneous ~Cr release 
Preparation of Antisera.--Rabbit antiserum against mouse ~-chain was kindly provided by 
Dr. H. Jaquet (Institute of Biochemistry, University of Lausanne). Rabbit antiserum against 
mouse Fab fragment was obtained after repeated subcutaneous injections of 1 mg  Fab incorpo- 
rated in complete Freund's adjuvant. Mouse IgG obtained by Pevikon block electrophoresis 
(9)  was digested with papain according to the method of Porter  (10)  using the conditions 
described previously (11). After digestion, the reaction mixture was applied to a diethylamino- 
ethyl (DEAE)-cellulose column equilibrated with 0.01  ~  sodium phosphate buffer, pH  8.0. 
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the source of Fab fragment after elimination of undigested IgG by gel filtration on Sephadex 
~100 (11). 
Mouse alloantisera were obtained after four or more monthly intraperitoneal injections of 
30 X 10  s tumor cells or 60 X 10  ° spleen cells from the appropriate strain of mice. Anti-~-CsH 
serum was prepared as described previously (12). 
Treatment with Antisera.--To study the origin of cells in spleens of irradiated mice injected 
with allogeneic  spleen cells, 0.1 ml volumes of spleen cells (2 X  106/ml) were mixed with 0.1 
ml of the corresponding alloantiserum diluted 1:10 in Eagle's medium and 0.1 ml of fresh 
rabbit serum as the source of complement. In the first series of experiments, unabsorbed rabbit 
serum was used at a dilution of 1:8, while rabbit serum diluted 1:4 after absorption with agar 
(13) was employed in subsequent studies. The reaction mixtures were incubated for 45 rain at 
37°C. The proportion  of dye-excluding cells was determined by adding 0.1  ml of 0.16% 
trypan blue to each tube. 
The effect of antisera against mouse/z-chain and Fab fragment on plaque formation and 
cytotoxicity was tested  by adding 1/10-1/20  (v/v) antiserum to the spleen cell-target cell 
mixtures. Before use, the rabbit antisera were heat-inactivated  (30 rain, 56°C) and absorbed 
with the tumor cells used as target cells in each assay system. Normal rabbit serum was used 
as control. 
Susceptibility of alloantibody-forming cells and cytotoxic lymphocytes to treatment with 
anti-~-serum and complement was tested as follows: 50-100 X  106 spleen cells obtained 5 
days after transfer were mixed with AKR anti~-C3H serum (final  dilution 1:20) and agar- 
absorbed rabbit serum (final  dilution 1  : 12) in a total volume of 6.0 ml. After incubation for 
15 rain at 4°C and 45 rain at 37°C, the cells were washed twice by centrifugation, adjusted to 
the appropriate concentration of living cells as determined by a dye-exclusion  test, and tested 
in both in vitro assay systems as described above. 
RESULTS 
Origin of Cells in Spleens of Irradiated Mice Injected with Allogeneic Spleen 
Cells.--Groups  of DBA/2  or  C57BL/6 mice were irradiated (800 R)  and in- 
jected intravenously with 50 X  l0  G  spleen ceils from C57BL/6 or DBA/2 mice 
respectively. 4  days later,  the  genotype of the lymphoid cells present in the 
recipient spleens was determined individually using cytotoxic antisera against 
the  alloantigens of  the  donor  and the  re .ipient strain.  Susceptibility to  the 
cytotoxic activity of anti-~-serum was tested in parallel. As shown in Table I, 
most, if not all, lymphoid cells carried the alloantigens of the donor strain. In 
addition, about 65-70% of these cells were susceptible to treatment with anti- 
P-serum, a  percentage which is much higher than that of normal spleen cells 
before transfer into irradiated allogeneic recipients (about 30-40%)  2 (14). Simi- 
lar experiments performed on mice 5  days after irradiation and transfer gave 
essentially the same results. 
Detection of Alloantibody PFC.--When tumor cells bearing alloantigens of the 
DBA/2 strain were mixed in agarose with lymphoid cells obtained from spleens 
of  lethally irradiated  DBA/2  mice  injected 5  days  earlier with  100  X  106 
C57BL/6 spleen cells, it was found that circular areas of lysis appeared after the 
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addition  of complement  (7).  As  compared  to  the  plaque  assay  described  by 
Jerne and Nordin (15) for the detection of cells producing lytic antibody against 
heterologous erythrocytes, two modifications were found to be crucial for the 
detection of alloantibody PFC. First, rabbit serum had to be used as the source 
of complement, while guinea pig  serum was ineffective;  second,  areas of lysis 
were not detectable  at the end of the incubation period with complement, but 
TABLE I 
Origin  of Cells in Spleens of Irradiated Mice Injected with Allogeneic Spleen Cells* 
Per cent reduction in cell number after treatment 
Transferred  Irradiated  with complement and antiserum:~ 
spleen cells  recipient  C57BL/6  DBA/2  AKR 
Anti-DBA/2  Anti-C57BL/6  Anti-0-C3H 
C57BL/6  DBA/2  0  (0-9)  81  (70-89)  68  (64-78) 
DBA/2  C57BL/6  80  (70-89)  0  (0-3)  64  (61-84) 
* 50  X  l0  s spleen cells were injected  into  800 R-irradiated  mice  (five animals/group). 
Lymphoid cells present in the individual recipient spleen were collected 4 days after transfer. 
~C As compared with cells treated with complement alone. Numbers  in parentheses  indi- 
cate the range of values. 
TABLE II 
Specificity of the Alloantibody  PFC 
Transferred spleen ceils*  Irradiated recipients  Indicator cells  PFC/106  PFC/spleen 
C57BL/6  0  0 
C57BL/6  DBA/2 
DBA/2  9.0  260 
C57BL/6  9.7  160 
DBA/2  C57BL/6 
DBA/2  0  0 
* 100 X  l0  s spleen cells were injected intravenously into 800 R-irradiated  allogeneic mice. 
Lymphoid cells present in the recipient spleens were collected 5 days after transfer. 
appeared after an additional 24 hr incubation in normal medium. These findings 
reflect (a) the superior activity of rabbit serum as the source of complement in 
immune tysis of nucleated cells as compared to guinea pig serum (16),  and (b) 
the  longer incubation  time  required  for visible  disintegration  of lysed  tumor 
cells  incorporated in agarose as compared to red  cells.  Moreover,  tumor  cells 
could not be replaced by red cells  as the  source of alloantigen-bearing  target 
cells, probably because of the much lower alloantigen content of the latter cells. 
The specificity of the plaque assay system was assessed by using target cells 
specific  for the  DBA/2  or  C57BL/6  strain,  and  C57BL/6  or DBA/2  spleen 
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plaque formation occurred only with target cells syngeneic to the spleen cell re- 
cipient strain, but not with target cells syngeneic to the spleen cell donor strain. 
Since normal spleens contained no naturally occurring alloantibody PFC, these 
results indicated  that  alloantibody PFC  were formed after transfer of spleen 
cells into allogeneic  recipients. 
Detection of Cytotoxic Lymphocytes.--The  transferred spleen cell  populations 
were also tested for in vitro cytotoxicity using the assay system described pre- 
viously (6). For that purpose, the DBA/2  tumor cells used  as  target  cells  in 
the plaque  assay system were labeled with  51Cr and incubated  in  suspension 
TABLE  III 
61Cr Release  from Labeled DBA /2 Target Cells Incubated with Syngeneic or 
AUogeneic Spleen Cells* 
Lymphoid  cells  Percent ~tCr release~ 
None 
Normal C57BL spleen cells 
DBA/2  spleen cells transferred  into irradi- 
ated I)BA/2 mice§ 
C57BL spleen cells transferred into irradiated 
DBA/2 mice§ 
2hr  4hr  6hr 
8.1  12.9  16.7 
8.3  13.2  16.0 
8.2  12.7  15.1 
28.0  48.1  63.7 
* Lymphoid cell:targ'et cell ratio of 100:1 
~: 86% of incorporated 51Cr released by treatment with distilled water (= 100% lysis). 
§ 800 R-irradiated mice were injected intravenously with 50 X 106 spleen cells from DBA/2 
or C57BL/6 mice. Lymphoid cells present in the recipient spleens were collected 4 days after 
transfer. 
with C57BL/6 spleen cells transferred into irradiated DBA/2 mice. 51Cr release 
from the target cells was measured after incubation for 2, 4, and 6 hr and com- 
pared with that observed in suspensions containing target cells alone or target 
cells and normal C57BL/6 or DBA/2 spleen cells. As indicated in Table III, the 
amount of 51Cr released from target cells in the presence of transferred C57BL/6 
spleen cells increased rapidly during  the  incubation period,  reaching 64%  of 
the incorporated isotope after 6 hr. On the other hand, there was no difference 
between  51Cr release from target cells incubated  alone or with normal spleen 
cells.  In the subsequent experiments, the percentage of specific lysis was calcu- 
lated using the formula given in Materials and Methods. 
To substantiate these findings, spleen cells from various mouse  strains were 
injected  into  irradiated  allogeneic  mice  and  tested  for  in  vitro  cytotoxicity 
using 51Cr-labeled  target cells syngeneic to the recipient strain. Table  IV illus- 
trates the strain combinations investigated and the percentage  of target cell- 
specific lysis  observed.  It  can  be  seen  that  high  levels  of  cytotoxicity were 
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Non-H-2  differences between  the cell donor  and  the recipient  strains  resulted 
in smaller but definite cytotoxicity as shown by the activity of BALB/c  (H-2 d) 
TABLE  IV 
Cytoxicity of Spleen Cells Sensitized by Transfer into Heavily Irradiated 
Allogeneic Recipients* 
Lymphocyte donor  Lymphocyte  recipient  Per cent specific  lysis in 6 hr  and target cell donor 
ratio :~1o  :1  30:1  lOO :  t 
C57BL/6  DBA/2  55  75  87 
C57BL/6  A  7  14  30 
C57BL/6  C~H  ND  ND  53 
A  DBA/2  43  62  ND 
A  C57BL/6  40  64  75 
DBA/2  C57BL/6  25  48  66 
C3H  DBA/2  35  66  ND 
AKR  DBA/2  34  61  ND 
BALB/c  DBA/2  ND  9  17 
ND: not done. 
* 50 X  106 spleen cells were injected intravenously into 800 R-irradiated mice. Recipient 
spleen cells were collected 4 days after transfer 
:~ Lymphocyte: target cell ratio. 
TABLE V 
Specificity of the Cytoxic Lymphoid Cells 
Transferred  Irradiated  Target cell mixture  Per cent specific 
lysis of labeled  spleen cells*  recipients  Labeled cell  Unlabeled  cell  target cell 
C57BL/6  DBA/2  DBA/2  --  71 
C57BL/6  --  0 
DBA/2  C57BL/6  DBA/2  --  0 
C57BL/6  --  76 
C57BL/6  DBA/2  DBA/2  C57BL/6  73 
C57BL/6  DBA/2  0 
DBA/2  C57BL/6  0 
DBA/2  C57BL/6  C57BL/6  DBA/2  40 
* 800 R-irradiated mice were injected intravenously with 50 X  106 spleen cells. Lymphoid 
cells present in the recipient spleens were collected 4  days later and  incubated with target 
cells for 6 hr (lymphoid cell:target cell ratio, 100:1). 
spleen  cells transferred  into irradiated  DBA/2  (I-I-2  a)  mice. The  specificity of 
the  cytotoxic  assay  system  was  assessed  by  testing  the  same  combination  of 
target  cells  and  transferred  spleen  cells  as  used  for  the  plaque  assay  system. 
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to the spleen  cell recipient  strain.  Moreover, nonspecific cytotoxicity was  not 
observed when target cells syngeneic to the spleen cell donor strain were added 
to a  mixture  of transferred  spleen  cells  and  target cells  syngeneic to the  cell 
recipient strain.  This absence of nonspecific cytotoxicity was demonstrated  by 
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FIG. 1. Effect  of  anti-immunoglobulin  antisera  on  alloantibody  plaque  formation  and 
cytotoxicity.  C57BL/6  spleen cells obtained  5 days after  transfer  into irradiated  (800 R) 
DBA/2 mice were assayed for alloantibody plaque formation and cytotoxicity using DBA/2 
target cells. Rabbit antisera to mouse #-chain or Fab fragment were added to the spleen cell- 
target cell reaction mixtures at a final dilution of 1 : 10 (cytotoxic assay) or 1: 20 (plaque assay). 
vice versa,  with  either  a  mixture  of 51Cr-labeled DBA/2  target cells  and un- 
labeled  C57BL/6  target  cells,  or  51Cr-labeled  C57BL/6  target  cells  and  un- 
labeled DBA/2 target cells  (Table V). The results confirmed previous studies 
(4)  demonstrating  that  51Cr release  in the presence of transferred  spleen  cells 
was restricted  to target cells carrying the sensitizing alloantigens,  namely the 
alloantigens of the recipient strain. 
Effect of Anti-Immunoglotrulin  Antisera  on  Alloantibody  Plaque  Formation 
and Cytotoxicity.--Since  both in vitro assays are based on target cell lysis,  it 
was of importance to establish that two different effector cells were involved in 560  CELLULAR AND  HUMORAL  RESPONSE  TO  ALLOANTIGENS 
each assay system. Previous studies have shown that the in vitro cytotoxicity 
of spleen cells from mice immunized with allografts was not inhibited by anti- 
sera against mouse imnmnoglobulins (17-18), while alloantibody plaque forma- 
tion was completely abolished in the presence of antibody against mouse/~-chain 
(4). The results of five similar experiments performed on spleen cells sensitized 
by transfer  into irradiated  allogeneic  recipients  are  summarized in Fig.  1.  It 
can be  seen  that  the  addition  of rabbit  antiserum  to mouse/z-chain or  Fab 
fragment caused, respectively, 99,  or 95 % reduction in PFC number, but had 
no significant effect on cytotoxicity. 
TABLE VI 
Inhibitory Activity of Alloantibody on Cytoxlclty of Sensitized Lymphocytes 
Irradiated  Lymphocyte:  Per cent 
Lymphocyte  recipient and  Antiserum~  target cell  donor*  specific lysis  target cell donor  ratio 
C57BL/6  DBA/2 





3:1  19 
10:1  44 
30:1  63 
30:1  17 
30:1  68 
10:1  13 
30:1  23 
100:1  31 
100:1  28 
100:1  12 
* 50 X 106 spleen cells injected intravenously  into 800 R-irradiated mice. Recipient spleen 
cells were collected 4 days later. 
{C Added to the reaction mixture at a final concentration of 1  : 10. 
§ Incubation time, 6 hr. 
Effect  on Cytotoxicity  of Alloantisera to  Target Cells or to Sensitized Lympho- 
cytes.--Another indication that alloantibody was not involved in the cytotoxic 
assay system was obtained from studies in which hyperimmune alloantiserum 
to target cells was added to the lymphoid cell-target cell mixture (Table VI). 
Cytotoxicity of sensitized lymphocytes was strongly inhibited in the presence 
of alloantiserum to target cell but was unaffected by the addition of alloanti- 
serum  against  the  lymphoid cells.  These  results,  as  well  as  previous  studies 
(5, 19), speak against a role for alloantibody in the cytotoxic effect of sensitized 
lymphocytes. 
Effect  of Anti-O-Antiserum  on Alloantibody  Plaque Formation  and  Cytotoxi- 
city.--Further  evidence that  cytotoxic lymphocytes were  quite  distinct  from 
alloantibody-forming cells was obtained by studying the susceptibility of both 
cell  types to treatment with anti-0-serum.  Spleen  cells  obtained  5  days  after J.-C.  CEROTTINI,  A.  A.  NORDIN,  AND  K.  T.  BRUNNER  561 
transfer into irradiated allogeneic recipients were treated in vitro with anti-0- 
serum and complement before the tests for alloantibody plaque formation and 
cytotoxicity. As indicated in Table VII, pretreatment with anti-0-serum and 
complement completely abolished the cytotoxic activity, but had no effect on 
alloantibody plaque  formation.  In  fact,  on  a  living  cell  basis,  the  anti-0- 
treated spleen cell population was enriched in alloantibody PFC as compared 
with controls. 
TABLE  VII 
Effect of Pretreatment of Transferred Spleen  Cdls with anti-O-Serum  and Complement on 
In Vitro  Cytotoxicity and Alloantibody  Plaque Formation* 
Pretreatment  of spleen cells:~  Per cent specific lysis in 6 hr§  PFC/10  s spleen ceils§ 
None  45  11.3 
NMS +  C  47  10.5 
Anti-0 +  C  0  42.0 
* 100  X  l0  s C57BL/6 spleen cells were injected into 800 R-irradiated DBA/2 mice. The 
lymphoid cells present in the recipient spleens were collected 5 days later, pretreated in vitro 
with anti-0-serum, and tested using DBA/2 target cells. 
:~ Cell samples (50 X  106 cells) were incubated with normal AKR serum (NMS), or AKR 
anti-8-C3H serum (anti-0), and rabbit serum as the source of complement (C) for 15 min at 
4°C and 45 min at 37°C. 
§ Lymphoid cell:target cell ratio  (30:1)  and  PFC/10 s spleen ceils based on cell counts 
performed after pretreatment. 
DISCUSSION 
The present studies demonstrate the development of two types of effector 
cells  after  transfer  of mouse  spleen  cells  into  lethally irradiated  Mlogeneic 
recipients,  namely alloantibody plaqueJorming  cells  and  cytotoxic lympho- 
cytes.  These  effector cells  have  been  shown  to  derive  from percursor  cells 
present in the transferred spleen cells and to be specifically sensitized against 
the recipient alloanfigens. In this respect, the immune process taking place in 
the transferred spleen cells is similar to that occurring in spleens of mice im- 
munized with allografts (4). 
Both types of effector cells could be detected in vitro since  lysis of target 
ceils carrying the host alloantigens occurred as an end result of their activity. 
Despite the fact that the in vitro assay systems for PFC and CL rely on the 
same phenomenon,  i.e.  target  cell  lysis,  ample  evidence has  been  obtained 
that they detect two separate types of effector cells which differ not only in 
their physicochemical properties,  but  also  in  their  origin.  Plaque  formation 
depends upon the release of IgM Mloantibody from PFC, requires the pres- 
ence of an appropriate source of complement (7),  and is inhibited by the ad- 
dition of antisera to mouse/~-chain or  Fab  fragment. The actual mechanism 562  CELLULAR  AND  HUMORAL RESPONSE  TO  ALLOANTIGENS 
by which CL destroy target cells is less  well understood (20).  The lyric event 
has  been  shown  to  depend  on  contact  between  viable  CL  and  target  cells 
(21), is independent of added complement or serum (5, 17),  and is not affected 
by antisera against the various mouse immunoglobulins (17-18), L  chains (17), 
or Fab fragment. 
Previous studies have  shown  that  the  lytic activity of CL  obtained from 
mice  immunized  with  allografts  was  inhibited  by  the  addition  of  antibody 
against target cell alloantigens (5, 19). These findings, confirmed by the present 
results  obtained  with  CL  sensitized  by  transfer,  speak  against  the  role  of 
alloantibody in  the  in  vitro activity of CL  and  suggest,  on  the contrary,  a 
mechanism of competition between alloantibody and CL for the  same  deter- 
minants on the target cell surface (19). 
Further indication that different cells are involved in plaque formation and 
in  vitro cytotoxicity has  been  obtained from fractionaticn studies  of spleen 
cells sensitized to alloantigens by differential flotation in discontinuous albumin 
density gradients (22). Most of the alloantibody PFC were found to collect in 
fractions containing cells of low density, while CL accumulated in fractions of 
intermediate and higher density. 
Recent studies  concerning the  origin  of effector cells have clearly demon- 
strated that  CL belong to the  thymus-derived cells,  while alloantibody PFC 
derive from thymus-independent precursors. First, CL, but not PFC, are formed 
upon transfer of thymus cells into irradiated allogeneic recipients (23). Second, 
PFC, but not CL, appear after transfer of spleen cells pretreated with anti-0- 
serum  and  complement2 Third,  treatment  of spleen  cells  sensitized  to  allo- 
antigens with anti-0 and complement before in vitro assays for PFC and CL 
completely abolished  the  in  vitro  cytotoxic activity,  but  had  no  effect on 
plaque  formation (reference 12  and  this  paper).  It  is  therefore evident that 
CL,  contrary  to  alloantibody  PFC,  are  thymus-derived  cells,  and  as  such 
represent effector cells involved in cell-mediated immunity. 
The possibi]ity of differentiating CL  and  their  precursors  from PFC  and 
their precursors by virtue of their susceptibility to anti~-serum and comple- 
ment makes it feasible to study their relative pathological role in GVH reac- 
tions. It has been found that transfer of normal or sensitized parental spleen 
cells pretreated with  anti-0-serum  and  complement into F1 hybrids was  not 
followed by a  GVH reaction.  3 These data, together with the results presented 
in this paper, suggest that CL play the major role in the GVI-I disease. 
SUMMARY 
After  transfer  into  heavily-irradiated  allogeneic  mice,  spleen  cells  were 
found  to  produce  two  types  of effector cells directed  against  the  recipient 
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alloantigens,  namely  alloantibody  plaque-forming cells  (PFC)  and  cytotoxic 
lymphocytes  (CL).  Both  types  of  effector cells  were  detectable  in  vitro  by 
virtue of their lyric effect on target cells carrying the recipient alloantigens. 
Alloantibody PFC activity was dependent on the presence of  an  exogenous 
source of complement and could be inhibited by the addition  of heterologous 
antisera to mouse u-chain or Fab fragment in the assay system. CL activity was 
independent  of added complement,  was not affected by anti-immunoglobulin 
antisera,  but  was  inhibited  by  the  addition  of  antibody  against  target  cell 
alloantigens. Treatment of the  transferred spleen cells with  anti-0-serum and 
complement before in vitro assays for PFC  and CL completely abolished the 
CL activity but had no effect on alloantibody-plaque formation. These results 
indicate  that the two types of effector cells can be differentiated in vitro by 
virtue  of their susceptibility  to  anti-0-serum  and  the  mechanisms by which 
they cause cell lysis. 
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